HK1075039A1 - Short-acting sedative hypnotic agents for anesthesia and sedation - Google Patents

Short-acting sedative hypnotic agents for anesthesia and sedation

Info

Publication number
HK1075039A1
HK1075039A1 HK05107428.2A HK05107428A HK1075039A1 HK 1075039 A1 HK1075039 A1 HK 1075039A1 HK 05107428 A HK05107428 A HK 05107428A HK 1075039 A1 HK1075039 A1 HK 1075039A1
Authority
HK
Hong Kong
Prior art keywords
sedation
anesthesia
short
hypnotic agents
sedative hypnotic
Prior art date
Application number
HK05107428.2A
Other languages
English (en)
Inventor
Thomas E Jenkins
Sabine Axt
Jennifer Bolton
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of HK1075039A1 publication Critical patent/HK1075039A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK05107428.2A 2002-01-25 2005-08-24 Short-acting sedative hypnotic agents for anesthesia and sedation HK1075039A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35138502P 2002-01-25 2002-01-25
US37921902P 2002-05-09 2002-05-09
PCT/US2003/002227 WO2004037750A2 (en) 2002-01-25 2003-01-24 Short-acting sedative hypnotic agents for anesthesia and sedation

Publications (1)

Publication Number Publication Date
HK1075039A1 true HK1075039A1 (en) 2005-12-02

Family

ID=32179539

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05107428.2A HK1075039A1 (en) 2002-01-25 2005-08-24 Short-acting sedative hypnotic agents for anesthesia and sedation

Country Status (22)

Country Link
US (4) US6887866B2 (xx)
EP (1) EP1509492B1 (xx)
KR (2) KR100951846B1 (xx)
CN (1) CN1257152C (xx)
AT (1) ATE522498T1 (xx)
AU (1) AU2003299453B2 (xx)
BR (1) BRPI0307017B1 (xx)
CA (1) CA2474262C (xx)
CY (1) CY1112487T1 (xx)
DK (1) DK1509492T3 (xx)
ES (1) ES2371461T3 (xx)
HK (1) HK1075039A1 (xx)
IL (3) IL162862A0 (xx)
MX (1) MXPA04007023A (xx)
NZ (1) NZ534012A (xx)
PL (1) PL207038B1 (xx)
PT (1) PT1509492E (xx)
RU (1) RU2315037C2 (xx)
SI (1) SI1509492T1 (xx)
TW (1) TWI290466B (xx)
WO (1) WO2004037750A2 (xx)
ZA (1) ZA200405561B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0307017B1 (pt) 2002-01-25 2015-11-10 Theravance Biopharma R & D Ip Llc compostos de éster de ácido fenilacético, composições farmacêuticas e uso de ditos compostos para preparar um medicamento útil para induzir ou manter a anestesia ou sedação
DE602004023509D1 (de) * 2003-07-23 2009-11-19 Theravance Inc Pharmazeutische zusammensetzungen eines kurzwirkenden sedativen hypnosemittels
US8329744B2 (en) * 2005-11-02 2012-12-11 Relmada Therapeutics, Inc. Methods of preventing the serotonin syndrome and compositions for use thereof
WO2008134071A1 (en) * 2007-04-26 2008-11-06 Theraquest Biosciences, Inc. Multimodal abuse resistant extended release formulations
US20090082466A1 (en) * 2006-01-27 2009-03-26 Najib Babul Abuse Resistant and Extended Release Formulations and Method of Use Thereof
US20090286832A1 (en) * 2008-05-15 2009-11-19 Kiichiro Nabeta Narcotic emulsion formulations for treatment of surgical pain
JP2012533621A (ja) 2009-07-22 2012-12-27 ピュアテック ベンチャーズ ムスカリン性受容体活性化によって改善される疾患の治療のための方法および組成物
CN102190580A (zh) * 2010-03-12 2011-09-21 重庆欣欣向荣精细化工有限公司 乙基香兰素合成中间体3-乙氧基-4-羟基扁桃酸的制备方法
JP5617034B2 (ja) * 2010-05-13 2014-10-29 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ 催眠・鎮静剤の注入可能なエマルション
CN102863353A (zh) * 2012-07-27 2013-01-09 华中科技大学 取代的苯基乙酸酯化合物及其应用
CN103450009B (zh) * 2013-09-02 2015-04-22 江苏宝众宝达药业有限公司 一种对羟基苯乙酸的制备方法
CN105272871B (zh) * 2014-06-20 2017-08-22 济南蓝丹医药科技有限公司 具有提高的药代动力学性能和麻醉性能的苯基乙酸酯类化合物
CN104211615B (zh) * 2014-08-12 2017-11-03 武汉珈瑜科技有限公司 苯基氟取代的苯乙酸酯化合物及其应用
CN104262292B (zh) * 2014-09-08 2019-02-22 武汉珈瑜科技有限公司 苯乙酸酯化合物及其应用
CN104622806B (zh) * 2015-02-04 2018-03-16 北京蓝丹医药科技有限公司 一种丙泮尼地药物组合物及其制备方法
CN104887628A (zh) * 2015-06-02 2015-09-09 北京蓝丹医药科技有限公司 一种稳定的苯基乙酸酯类药物脂肪乳
CN104887629A (zh) * 2015-06-09 2015-09-09 北京蓝丹医药科技有限公司 一种稳定的丙泮尼地脂肪乳
CN115581696A (zh) 2018-09-28 2023-01-10 卡鲁娜治疗学有限公司 用于治疗由毒蕈碱受体激活所缓解的障碍的组合物和方法
US20230167045A1 (en) 2020-04-27 2023-06-01 Symrise Ag Method for producing esters of homovanillic acid

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086976A (en) 1959-01-23 1963-04-23 Egyt Gyogyszervegyeszeti Gyar Benzoic acid derivatives and process for producing same
US3086978A (en) * 1960-05-06 1963-04-23 Bayer Ag 3-methoxy-4-carbamidomethoxy-phenylacetic acid esters
DE1134981B (de) * 1960-05-06 1962-08-23 Bayer Ag Verfahren zur Herstellung von N-substituierten 3-Methoxy-4-carbamidomethoxyphenylessigsaeurealkyl- und alkenylestern
US3088978A (en) * 1960-09-12 1963-05-07 Walter H Brunner Catalytic hydrogenation of 2, 4-dinitrophenylamines
BE624258A (xx) 1961-10-31
NL286944A (xx) 1961-12-20
US3510559A (en) 1964-01-10 1970-05-05 Geigy Chem Corp 2-alkoxyphenoxy-acetamides as anesthetics agents
CH432494A (de) 1964-01-10 1967-03-31 Geigy Ag J R Verfahren zur Herstellung neuer Aryloxyessigsäureamide
US3511877A (en) 1964-02-11 1970-05-12 Geigy Chem Corp Phenoxyacetic acid diethylamides
DE1249851B (de) 1964-02-11 1967-09-14 J R Geigy A G Basel (Schweiz) Morel Ariesheim (Schweiz) j Verfahren zur Herstellung neuer Phenoxyessigsäure amide
DE1518819B1 (de) 1965-04-03 1969-12-04 Basf Ag Loesungsvermittler fuer pharmazeutische Zwecke
US3484537A (en) * 1969-03-03 1969-12-16 American Mach & Foundry Photocontrol enclosure and support
US4798846A (en) 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1571395A (en) 1976-07-12 1980-07-16 Delmar Chem Substituted phenyl acetic acid esters
JPS5699440A (en) 1980-01-11 1981-08-10 Ube Ind Ltd Preparation of 3-alkoxy-4-hydroxyphenylacetic acid
ATE11736T1 (de) 1980-12-23 1985-02-15 Dr. Franz Koehler Chemie Gmbh Protektive loesung fuer herz und niere und verfahren zu deren herstellung.
JPS6038343A (ja) * 1983-08-11 1985-02-27 Mitsubishi Petrochem Co Ltd フエニル酢酸誘導体の製造方法
DE3339236A1 (de) 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
US4918092A (en) * 1983-12-21 1990-04-17 Merck Frosst Canada, Inc. Leukotriene antagonists
IT1204778B (it) * 1986-02-04 1989-03-10 Mazzarella Basilio Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
US5092838A (en) 1989-11-30 1992-03-03 Baxter International Inc. Histidine buffered peritoneal dialysis solution
US4981092A (en) * 1989-11-17 1991-01-01 R. G. Barry Corporation Fabric clamping device for embroidery machines
US5242944A (en) * 1991-06-20 1993-09-07 Korea Research Institute Of Chemical Technology Phenylacetamide derivatives and pharmaceutical compositions thereof
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
JPH0926544A (ja) * 1995-07-10 1997-01-28 Nikon Corp 顕微鏡用中間鏡筒
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
BR9907832A (pt) 1998-02-10 2000-10-31 Sicor Inc Composição de propofol contendo sulfito
US6028108A (en) 1998-10-22 2000-02-22 America Home Products Corporation Propofol composition comprising pentetate
US6140374A (en) 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6140373A (en) 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6177477B1 (en) 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
CA2412905A1 (en) 2000-06-16 2001-12-27 Rtp Pharma Inc. Improved injectable dispersions of propofol
BRPI0307017B1 (pt) * 2002-01-25 2015-11-10 Theravance Biopharma R & D Ip Llc compostos de éster de ácido fenilacético, composições farmacêuticas e uso de ditos compostos para preparar um medicamento útil para induzir ou manter a anestesia ou sedação

Also Published As

Publication number Publication date
AU2003299453A1 (en) 2004-05-13
US20090253787A1 (en) 2009-10-08
BR0307017A (pt) 2006-04-11
CA2474262A1 (en) 2004-05-06
MXPA04007023A (es) 2004-10-14
EP1509492A2 (en) 2005-03-02
IL201639A (en) 2011-12-29
TWI290466B (en) 2007-12-01
DK1509492T3 (da) 2011-11-28
EP1509492B1 (en) 2011-08-31
IL162862A (en) 2011-04-28
WO2004037750A3 (en) 2005-01-06
KR20080070087A (ko) 2008-07-29
RU2315037C2 (ru) 2008-01-20
US20030153554A1 (en) 2003-08-14
KR100925790B1 (ko) 2009-11-11
CN1622934A (zh) 2005-06-01
US7514425B2 (en) 2009-04-07
IL162862A0 (en) 2005-11-20
RU2004125854A (ru) 2005-05-20
US20050113364A1 (en) 2005-05-26
KR20040093693A (ko) 2004-11-08
CN1257152C (zh) 2006-05-24
SI1509492T1 (sl) 2012-03-30
AU2003299453B2 (en) 2007-11-29
US7015346B2 (en) 2006-03-21
US7939689B2 (en) 2011-05-10
CY1112487T1 (el) 2015-12-09
US20060116424A1 (en) 2006-06-01
ATE522498T1 (de) 2011-09-15
WO2004037750A2 (en) 2004-05-06
PT1509492E (pt) 2011-11-21
CA2474262C (en) 2011-03-15
ZA200405561B (en) 2005-10-26
KR100951846B1 (ko) 2010-04-12
ES2371461T3 (es) 2012-01-03
NZ534012A (en) 2006-12-22
TW200425896A (en) 2004-12-01
PL207038B1 (pl) 2010-10-29
BRPI0307017B1 (pt) 2015-11-10
US6887866B2 (en) 2005-05-03
PL373420A1 (en) 2005-08-22

Similar Documents

Publication Publication Date Title
HK1075039A1 (en) Short-acting sedative hypnotic agents for anesthesia and sedation
UA89734C2 (xx) Антагоністи мускаринових ацетилхолінових рецепторів $антагонисты мускариновых ацетилхолиновых рецепторов
MXPA04008068A (es) Metodo para administrar moleculas de glp-1.
SG150533A1 (en) 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2- quinoxalinones as poly(adp-ribose) polymerase inhibitors
HK1115590A1 (en) Triazolophthalazines
WO2007064797A3 (en) Inhibitors of c-met and uses thereof
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
EP1740183B8 (en) Novel use for pde5 inhibitors
ITMO20020321A0 (it) Gruppo per la miscelazione di fluidi inseribile lungo linee di trasporto e-o distribuzione,particolarmente per la miscelazione di fluidi dia
MX2009002842A (es) Inhibidores heterociclicos de c-met y usos de los mismos.
AU2003256410A8 (en) Combination therapy with p38 map kinase inhibitors and their pharmaceutical compositions
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
GB2390367B (en) Lipid profile modulation
TW200505443A (en) Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
TW200510398A (en) Novel compounds
MXPA05013478A (es) Combinaciones terapeuticas.
HK1090841A1 (en) Pharmaceutical compositions of short-acting sedative hypnotic agent
SE0301654D0 (sv) Novel compounds
SE0302361D0 (sv) Inhibering av upptagning av monoamin
WO2003026632A3 (en) Substituted phenol compounds useful for anesthesia and sedation
IL139144A0 (en) Mycobacterial inhibitors
WO2005023744A3 (en) Calixarenes as inhibitors of protein kinase b
NO20043509L (no) Kortvirkende sedative hypnotika for anestesi og sedatering
UY27706A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual.
TW200500012A (en) Novel lactobacillus and use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180124